Related Experiment Video
Updated: Jul 12, 2026

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16
Published on: July 15, 2019
Interaction of decay-accelerating factor with coxsackievirus B3
Susan Hafenstein1, Valorie D Bowman, Paul R Chipman
1Department of Biological Sciences, Purdue University, 915 W. State Street, West Lafayette, IN 47907-2054, USA.
Abstract:
Many entero-, parecho-, and rhinoviruses use immunoglobulin (Ig)-like receptors that bind into the viral canyon and are required to initiate viral uncoating during infection. However, some of these viruses use an alternative or additional receptor that binds outside the canyon. Both the coxsackievirus-adenovirus receptor (CAR), an Ig-like molecule that binds into the viral canyon, and decay-accelerating factor (DAF) have been identified as cellular receptors for coxsackievirus B3 (CVB3). A cryoelectron microscopy reconstruction of a variant of CVB3 complexed with DAF shows full occupancy of the DAF receptor in each of 60 binding sites. The DAF molecule bridges the canyon, blocking the CAR binding site and causing the two receptors to compete with one another. The binding site of DAF on CVB3 differs from the binding site of DAF on the surface of echoviruses, suggesting independent evolutionary processes.
Insights
Many viruses use immunoglobulin (Ig)-like receptors to infect cells. This study reveals how decay-accelerating factor (DAF) binds to coxsackievirus B3, blocking other receptors and highlighting distinct viral evolutionary paths.
Area of Science:
- Virology
- Structural Biology
- Immunology
Background:
- Enteroviruses, rhinoviruses, and parechoviruses commonly utilize immunoglobulin (Ig)-like receptors that bind within viral canyons to initiate infection.
- Some viruses employ alternative receptors that bind outside the viral canyon.
- Coxsackievirus B3 (CVB3) is known to use both the coxsackievirus-adenovirus receptor (CAR) and decay-accelerating factor (DAF) as cellular receptors.
Purpose of the Study:
- To elucidate the structural basis of CVB3 interaction with DAF.
- To understand the competitive binding mechanism between DAF and CAR for CVB3.
- To investigate the evolutionary implications of DAF binding sites across different viruses.
Main Methods:
- Cryoelectron microscopy was used to determine the structure of CVB3 complexed with DAF.
- Analysis of receptor binding sites on the viral surface.
- Comparative analysis of DAF binding sites on CVB3 and echoviruses.
Main Results:
- A cryoelectron microscopy reconstruction revealed DAF binding to all 60 sites on the CVB3 variant.
- DAF binding bridges the viral canyon, sterically hindering the CAR binding site.
- The DAF binding site on CVB3 is distinct from that observed on echoviruses.
Conclusions:
- DAF acts as a receptor for CVB3, competing with CAR for viral binding.
- The distinct DAF binding site on CVB3 suggests independent evolutionary adaptation compared to echoviruses.
- Understanding these receptor interactions provides insights into viral entry mechanisms and evolution.
Related Concept Videos
Cytomegalovirus Disease
Interference and Decay
Interference occurs when competing memories hinder the retrieval of particular information. It can be classified into two types: proactive and retroactive interference. Proactive...
Inhibitors of Virion Maturation and Assembly
Factors Affecting Activity Coefficient
The activity coefficient value for an ion is close to one when the solution has almost zero ionic strength, i.e., when the solution shows close to ideal behavior. As the ionic strength of the solution increases from 0 to 0.1 mol/L, a decrease in the...
Respiratory Syncytial Virus Disease
Inhibitors Of Virion Release

